Lensar (LNSR) Preferred Stock Liabilities (2019)
Lensar's (LNSR) quarterly Preferred Stock Liabilities came in at $36.4 million in Q4 2019.
Lensar (LNSR) Preferred Stock Liabilities (2019) Analysis & Trends
Lensar (LNSR) has 1 years of Preferred Stock Liabilities data on file, last reported at $36.4 million in Q4 2019.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $36.4 million in Q4 2019; TTM through Dec 2019 was $36.4 million, a N/A change from a year earlier, with the FY2019 full-year figure at $36.4 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q4 2019 stood at $36.4 million.
- Over the last five years, Preferred Stock Liabilities for LNSR reached as high as $36.4 million in Q4 2019 and fell as low as $36.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.42 Mn |